UBS keeps AUD 135.00 target for Cochlear stock

Published on 10/15/2026 at 22:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Quarter revenue was AUD 1.16 billion for the period ended June 30, 2026. Cochlear stock costs EUR 79.60 on October 15, 2026, with ASX at AUD 128.72.

Analyst view and trading dates

UBS analyst David Low maintained a Hold rating and set an AUD 135.00 target on October 14, 2026.
Cochlear reported AUD 1.16 billion in quarterly revenue and a GAAP net loss of AUD 14.20 million for the period ended June 30, 2026.
Cochlear stock cost EUR 79.60 at Lang & Schwarz on October 15, 2026 at 10:11 p.m. CEST.
Cochlear's annual general meeting is scheduled for October 26, 2026.

Cochlear, AU000000COH5, Illustration mit AI erstellt.

Cochlear (AU000000COH5) received a fresh AUD 135.00 target from UBS on October 14, 2026, while analyst David Low maintained a Hold rating, according to Markets Insider. The target stood 4.88 percent above Cochlear's ASX price of AUD 128.72. Cochlear stock was trading at EUR 79.60 at Lang & Schwarz on October 15, 2026 at 10:11 p.m. CEST.

Quarter revenue reached AUD 1.16 billion

The latest reported quarter ended June 30, 2026, with revenue of AUD 1.16 billion, down from AUD 1.19 billion a year earlier. Cochlear also reported a GAAP net loss of AUD 14.20 million, compared with a GAAP net profit of AUD 183.80 million in the prior-year quarter, according to Markets Insider. That earnings comparison remains the central fundamental backdrop for the current analyst stance.

Cochlear sits 56.59 percent below its high

The ASX quote was last at AUD 128.72 at 3:10 p.m. AEDT on October 15, 2026, down 0.43 percent on the day. Cochlear's 52-week range was AUD 88.74 to AUD 296.50, placing the share 45.07 percent above its low and 56.59 percent below its high. At Lang & Schwarz, the bid was EUR 78.81 and the ask EUR 80.39 on October 15, 2026.

P/E stands at 57.46

Cochlear had a market capitalization of AUD 8.4 billion and a price-to-earnings ratio of 57.46 as of October 15, 2026. The annual general meeting is scheduled as a hybrid event for October 26, 2026, according to Simply Wall St. The date gives investors the next clearly defined corporate appointment after the June 30 reporting period.

Comparison with peers

Cochlear (ASX, AUD): minus 0.43 percent, P/E 57.46, market capitalization AUD 8.4 billion
Sonova Holding (SIX, CHF): plus 1.41 percent, P/E 37.98, market capitalization CHF 16.3 billion
Demant (Nasdaq Copenhagen, DKK): plus 1.18 percent, P/E 46.56, market capitalization DKK 75.7 billion

Euro quote after the Xetra close

The Lang & Schwarz euro quote places Cochlear at EUR 79.60 on October 15, 2026 at 10:11 p.m. CEST, while the company's home-market price was AUD 128.72 at 3:10 p.m. AEDT. The different currencies make the ASX valuation metrics the relevant comparison for the analyst target. The further course of trading is shown by the continuously updated real-time quote of Cochlear stock.